Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model

Chara A. Kyriakou, Kwee L. Yong, Reuben Benjamin, Arnold Pizzey, Ahmet Dogan, Nalini Singh, Andrew M. Davidoff, Amit C. Nathwani

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: Efficient gene transfer to bone marrow derived mesenchymal stem cells (MSC) would provide an important opportunity to express potent anticancer agents in the tumour microenvironment because of their contribution to the tumour stroma. Methods: HIV-based lentiviral vectors were pseudotyped with four different envelope proteins; amphotropic murine leukaemia virus (ampho), murine leukaemia virus (10A1), feline endogenous virus (RD114), and the vesicular stomatitis virus glycoprotein (VSVG). These pseudotypes were examined for transduction efficiency in human bone marrow derived MSC. The effect of lentiviral expression of truncated soluble vascular endothelial growth factor decoy receptor (tsFlk-1) in MSC on growth of Raji cells was determined, both in vitro and in vivo. Results: All lentiviral vectors produced significant levels of transduction at an multiplicity of infection (MOI) of 1, those bearing the RD114 envelope glycoprotein consistently produced higher transduction levels (mean 70 ± 6%) compared with the other pseudotyped lentiviral vectors, although there was significant inter-donor variation. Stable transgene expression was achieved after multiple rounds of transduction with VSVG-pseudotyped particles, without alteration in the differentiative capacity of transduced cells. Co-injection of MSC stably expressing tsFlk-1 with Raji Burkitt's lymphoma cells significantly impaired subcutaneous tumour growth in immunodeficient mice when compared to controls where either unmanipulated MSC or GFP-expressing MSC were used. Conclusions: Human MSC are easily transduced by pseudotyped lentiviral particles but there is inter-donor variation in transduction efficiency. Gene-modified MSC expressing a gene of therapeutic potential can moderate growth of haematological malignancies.

Original languageEnglish (US)
Pages (from-to)253-264
Number of pages12
JournalJournal of Gene Medicine
Volume8
Issue number3
DOIs
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor Receptor-1
Burkitt Lymphoma
Mesenchymal Stromal Cells
Growth
Genes
Murine Leukemia Viruses
Glycoproteins
Vesicular Stomatitis
Viruses
Bone Marrow
Vascular Endothelial Growth Factor Receptor
Tumor Microenvironment
Felidae
Hematologic Neoplasms
Transgenes
Antineoplastic Agents
Neoplasms
HIV
Injections

Keywords

  • Bone marrow derived mesenchymal stem cells
  • Lentiviral vectors

ASJC Scopus subject areas

  • Genetics

Cite this

Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. / Kyriakou, Chara A.; Yong, Kwee L.; Benjamin, Reuben; Pizzey, Arnold; Dogan, Ahmet; Singh, Nalini; Davidoff, Andrew M.; Nathwani, Amit C.

In: Journal of Gene Medicine, Vol. 8, No. 3, 03.2006, p. 253-264.

Research output: Contribution to journalArticle

Kyriakou, Chara A. ; Yong, Kwee L. ; Benjamin, Reuben ; Pizzey, Arnold ; Dogan, Ahmet ; Singh, Nalini ; Davidoff, Andrew M. ; Nathwani, Amit C. / Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. In: Journal of Gene Medicine. 2006 ; Vol. 8, No. 3. pp. 253-264.
@article{126c3eae21d7480993e38e7f6555add9,
title = "Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model",
abstract = "Background: Efficient gene transfer to bone marrow derived mesenchymal stem cells (MSC) would provide an important opportunity to express potent anticancer agents in the tumour microenvironment because of their contribution to the tumour stroma. Methods: HIV-based lentiviral vectors were pseudotyped with four different envelope proteins; amphotropic murine leukaemia virus (ampho), murine leukaemia virus (10A1), feline endogenous virus (RD114), and the vesicular stomatitis virus glycoprotein (VSVG). These pseudotypes were examined for transduction efficiency in human bone marrow derived MSC. The effect of lentiviral expression of truncated soluble vascular endothelial growth factor decoy receptor (tsFlk-1) in MSC on growth of Raji cells was determined, both in vitro and in vivo. Results: All lentiviral vectors produced significant levels of transduction at an multiplicity of infection (MOI) of 1, those bearing the RD114 envelope glycoprotein consistently produced higher transduction levels (mean 70 ± 6{\%}) compared with the other pseudotyped lentiviral vectors, although there was significant inter-donor variation. Stable transgene expression was achieved after multiple rounds of transduction with VSVG-pseudotyped particles, without alteration in the differentiative capacity of transduced cells. Co-injection of MSC stably expressing tsFlk-1 with Raji Burkitt's lymphoma cells significantly impaired subcutaneous tumour growth in immunodeficient mice when compared to controls where either unmanipulated MSC or GFP-expressing MSC were used. Conclusions: Human MSC are easily transduced by pseudotyped lentiviral particles but there is inter-donor variation in transduction efficiency. Gene-modified MSC expressing a gene of therapeutic potential can moderate growth of haematological malignancies.",
keywords = "Bone marrow derived mesenchymal stem cells, Lentiviral vectors",
author = "Kyriakou, {Chara A.} and Yong, {Kwee L.} and Reuben Benjamin and Arnold Pizzey and Ahmet Dogan and Nalini Singh and Davidoff, {Andrew M.} and Nathwani, {Amit C.}",
year = "2006",
month = "3",
doi = "10.1002/jgm.840",
language = "English (US)",
volume = "8",
pages = "253--264",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model

AU - Kyriakou, Chara A.

AU - Yong, Kwee L.

AU - Benjamin, Reuben

AU - Pizzey, Arnold

AU - Dogan, Ahmet

AU - Singh, Nalini

AU - Davidoff, Andrew M.

AU - Nathwani, Amit C.

PY - 2006/3

Y1 - 2006/3

N2 - Background: Efficient gene transfer to bone marrow derived mesenchymal stem cells (MSC) would provide an important opportunity to express potent anticancer agents in the tumour microenvironment because of their contribution to the tumour stroma. Methods: HIV-based lentiviral vectors were pseudotyped with four different envelope proteins; amphotropic murine leukaemia virus (ampho), murine leukaemia virus (10A1), feline endogenous virus (RD114), and the vesicular stomatitis virus glycoprotein (VSVG). These pseudotypes were examined for transduction efficiency in human bone marrow derived MSC. The effect of lentiviral expression of truncated soluble vascular endothelial growth factor decoy receptor (tsFlk-1) in MSC on growth of Raji cells was determined, both in vitro and in vivo. Results: All lentiviral vectors produced significant levels of transduction at an multiplicity of infection (MOI) of 1, those bearing the RD114 envelope glycoprotein consistently produced higher transduction levels (mean 70 ± 6%) compared with the other pseudotyped lentiviral vectors, although there was significant inter-donor variation. Stable transgene expression was achieved after multiple rounds of transduction with VSVG-pseudotyped particles, without alteration in the differentiative capacity of transduced cells. Co-injection of MSC stably expressing tsFlk-1 with Raji Burkitt's lymphoma cells significantly impaired subcutaneous tumour growth in immunodeficient mice when compared to controls where either unmanipulated MSC or GFP-expressing MSC were used. Conclusions: Human MSC are easily transduced by pseudotyped lentiviral particles but there is inter-donor variation in transduction efficiency. Gene-modified MSC expressing a gene of therapeutic potential can moderate growth of haematological malignancies.

AB - Background: Efficient gene transfer to bone marrow derived mesenchymal stem cells (MSC) would provide an important opportunity to express potent anticancer agents in the tumour microenvironment because of their contribution to the tumour stroma. Methods: HIV-based lentiviral vectors were pseudotyped with four different envelope proteins; amphotropic murine leukaemia virus (ampho), murine leukaemia virus (10A1), feline endogenous virus (RD114), and the vesicular stomatitis virus glycoprotein (VSVG). These pseudotypes were examined for transduction efficiency in human bone marrow derived MSC. The effect of lentiviral expression of truncated soluble vascular endothelial growth factor decoy receptor (tsFlk-1) in MSC on growth of Raji cells was determined, both in vitro and in vivo. Results: All lentiviral vectors produced significant levels of transduction at an multiplicity of infection (MOI) of 1, those bearing the RD114 envelope glycoprotein consistently produced higher transduction levels (mean 70 ± 6%) compared with the other pseudotyped lentiviral vectors, although there was significant inter-donor variation. Stable transgene expression was achieved after multiple rounds of transduction with VSVG-pseudotyped particles, without alteration in the differentiative capacity of transduced cells. Co-injection of MSC stably expressing tsFlk-1 with Raji Burkitt's lymphoma cells significantly impaired subcutaneous tumour growth in immunodeficient mice when compared to controls where either unmanipulated MSC or GFP-expressing MSC were used. Conclusions: Human MSC are easily transduced by pseudotyped lentiviral particles but there is inter-donor variation in transduction efficiency. Gene-modified MSC expressing a gene of therapeutic potential can moderate growth of haematological malignancies.

KW - Bone marrow derived mesenchymal stem cells

KW - Lentiviral vectors

UR - http://www.scopus.com/inward/record.url?scp=33645211749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645211749&partnerID=8YFLogxK

U2 - 10.1002/jgm.840

DO - 10.1002/jgm.840

M3 - Article

C2 - 16288493

AN - SCOPUS:33645211749

VL - 8

SP - 253

EP - 264

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 3

ER -